Compare · JUPW vs LLY
JUPW vs LLY
Side-by-side comparison of Jupiter Wellness Inc. (JUPW) and Eli Lilly and Company (LLY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both JUPW and LLY operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
- LLY is the larger of the two at $1.20T, about 56458.8x JUPW ($21.3M).
- LLY has hit the wire 23 times in the past 4 weeks while JUPW has been quiet.
- LLY has more recent analyst coverage (25 ratings vs 0 for JUPW).
- Company
- Jupiter Wellness Inc.
- Eli Lilly and Company
- Price
- $1.52+12.96%
- $1272.71-0.69%
- Market cap
- $21.3M
- $1.20T
- 1M return
- -
- +7.19%
- 1Y return
- -
- +54.62%
- Industry
- Biotechnology: Pharmaceutical Preparations
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 23
- Recent ratings
- 0
- 25
Jupiter Wellness Inc.
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; and MiNA Therapeutics Limited. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Latest JUPW
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form EFFECT filed by Jupiter Wellness Inc.
- SEC Form POS AM filed by Jupiter Wellness Inc.
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events (Amendment)
- SEC Form POS AM filed by Jupiter Wellness Inc.
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form POS AM filed by Jupiter Wellness Inc.
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Jupiter Wellness Inc. filed SEC Form 8-K: Regulation FD Disclosure
Latest LLY
- Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial
- Patrik Jonsson to retire after 36 years; Ilya Yuffa named president, Lilly Global Markets
- Billions in New Plants, Trillions in Potential Obesity-Drug Revenue Over Two Decades
- Lilly declares fourth-quarter 2026 dividend
- Gabelli To Host 8th Annual Healthcare Symposium
- New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
- Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026
- SEC Form 3 filed by Eli Lilly and Company
- Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter
- Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020